The long-term space missions and helium ion (4He) radiotherapy require assessing of the consequences on the central nervous system. This study investigated the effects of total-body irradiation with 2 Gy helium ions on the brain of male Balb/c mice, focusing on cognitive function, microglial status, gene expression, and systemic metabolism. No statistically significant deficits in hippocampus-dependent behavior or spatial memory were detected. However, cellular and molecular alterations were detected. A decreased Iba1-positive cell density was observed at several post-irradiation time points, accompanied by morphological shifts towards a less ramified state. Gene expression analysis revealed a complex response, including a mixed neuroimmune activation profile, altered expression of redox-related genes, and downregulation of key defense genes. Metabolomics identified changes in 19 plasma metabolites consistent with alterations in energy and amino acid metabolism. Although 2 Gy did not manifest in overt cognitive impairment in the early delayed period, molecular and cellular alterations were detectable at 8 weeks, including decreased Iba1-positive cell density at several post-irradiation time points, changes in microglial morphology, altered expression of neuroimmune and redox-related genes, and systemic metabolic changes. These findings underscore the importance of multimodal assessment beyond behavioral testing in experimental models of helium-ion exposure. Because the exposure conditions used here differ from both the chronic mixed-field GCR environment and localized clinical helium-ion therapy, the results should be regarded as fundamental radiobiological observations rather than direct predictions of spaceflight or radiotherapy outcomes.
No takes yet. Share an insight, caveat, or question.
Sorokina et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: